An investigational oral selective orexin receptor 2 agonist significantly improved measures of wakefulness, sleepiness, and ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

As a dietitian who’s reviewed and tested dozens—if not hundreds—of products, I can confidently say supplements can make a ...

Menopausal support (energy, mood, muscle retention): creatine is a woman's powerful ally during the menopause face as it ...

Treatment with cenobamate may reduce seizure frequency among patients with drug-resistant epilepsy after 3 months.

Total Operating Expenses: Total operating expenses were $42.9 million for the first quarter of 2025, including research and ...

Frustrated by long wait times and high costs, some are turning away from traditional, insurance-based health care in search ...

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve ...

Frustrated by long wait times and high costs, some are turning away from traditional, insurance-based health care in search ...

Check out our guide on how to clean quartz countertops for advice on getting your surfaces sparkly like new—and important ...

ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout expected in 2H 2026 that will provide ...